{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:46:06Z","timestamp":1791859566200,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006334","name":"Uniwersytet Jana Kochanowskiego w Kielcach","doi-asserted-by":"publisher","award":["SUPB.RN.26.006"],"award-info":[{"award-number":["SUPB.RN.26.006"]}],"id":[{"id":"10.13039\/501100006334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10482-026-02429-0","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:08:47Z","timestamp":1790388527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Difficult relationships between humans and bacteria: associations between multiple sclerosis and the human microbiome"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2751-7304","authenticated-orcid":false,"given":"Julia","family":"Dul\u0119bska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7064-4655","authenticated-orcid":false,"given":"Zuzanna","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4827-755X","authenticated-orcid":false,"given":"Izabela","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4273-7841","authenticated-orcid":false,"given":"Amelia","family":"Szcze\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-9896","authenticated-orcid":false,"given":"El\u017cbieta","family":"Jasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-0492","authenticated-orcid":false,"given":"Wioletta","family":"Adamus-Bia\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"2429_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028944","volume":"9","author":"L Alfredsson","year":"2019","unstructured":"Alfredsson L, Olsson T (2019) Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med 9:a028944. https:\/\/doi.org\/10.1101\/cshperspect.a028944","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2429_CR2","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.33292","author":"S Amri Saroukolaei","year":"2016","unstructured":"Amri Saroukolaei S, Ghabaee M, Shokri H et al (2016) Evaluation of APR1 gene expression in Candida albicans strains isolated from patients with multiple sclerosis. Jundishapur J Microbiol. https:\/\/doi.org\/10.5812\/jjm.33292","journal-title":"Jundishapur J Microbiol"},{"key":"2429_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","volume":"26","author":"A Bar-Or","year":"2020","unstructured":"Bar-Or A, Pender MP, Khanna R et al (2020) Epstein\u2013Barr virus in multiple sclerosis: theory and emerging immunotherapies. Trends Mol Med 26:296\u2013310. https:\/\/doi.org\/10.1016\/j.molmed.2019.11.003","journal-title":"Trends Mol Med"},{"key":"2429_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63613-4","volume":"10","author":"I Baskara","year":"2020","unstructured":"Baskara I, Kerbrat S, Dagouassat M et al (2020) Cigarette smoking induces human CCR6+Th17 lymphocytes senescence and VEGF-A secretion. Sci Rep 10:6488. https:\/\/doi.org\/10.1038\/s41598-020-63613-4","journal-title":"Sci Rep"},{"key":"2429_CR5","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1073\/pnas.1711233114","volume":"114","author":"K Berer","year":"2017","unstructured":"Berer K, Gerdes LA, Cekanaviciute E et al (2017) Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci USA 114:10719\u201310724. https:\/\/doi.org\/10.1073\/pnas.1711233114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2429_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC et al (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222","journal-title":"Science"},{"key":"2429_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-57949-4","volume":"14","author":"L Boussamet","year":"2024","unstructured":"Boussamet L, Montassier E, Math\u00e9 C et al (2024) Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study. Sci Rep 14:7786. https:\/\/doi.org\/10.1038\/s41598-024-57949-4","journal-title":"Sci Rep"},{"key":"2429_CR8","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awy131","volume":"141","author":"CR Camara-Lemarroy","year":"2018","unstructured":"Camara-Lemarroy CR, Metz L, Meddings JB et al (2018) The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain 141:1900\u20131916. https:\/\/doi.org\/10.1093\/brain\/awy131","journal-title":"Brain"},{"key":"2429_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103798","volume":"76","author":"C Cantoni","year":"2022","unstructured":"Cantoni C, Lin Q, Dorsett Y et al (2022) Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine 76:103798. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103798","journal-title":"EBioMedicine"},{"key":"2429_CR10","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF et al (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA 114:10713\u201310718. https:\/\/doi.org\/10.1073\/pnas.1711235114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2429_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep28484","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J, Chia N, Kalari KR et al (2016) Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep 6:28484. https:\/\/doi.org\/10.1038\/srep28484","journal-title":"Sci Rep"},{"key":"2429_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100032","volume":"3","author":"SN Choile\u00e1in","year":"2020","unstructured":"Choile\u00e1in SN, Kleinewietfeld M, Raddassi K et al (2020) CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. J Transl Autoimmun 3:100032. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100032","journal-title":"J Transl Autoimmun"},{"key":"2429_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrneurol.2010.147","volume":"6","author":"CS Constantinescu","year":"2010","unstructured":"Constantinescu CS, Gran B (2010) Autoimmune associations in multiple sclerosis. Nat Rev Neurol 6:591\u2013592. https:\/\/doi.org\/10.1038\/nrneurol.2010.147","journal-title":"Nat Rev Neurol"},{"key":"2429_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700492","author":"I Cosorich","year":"2017","unstructured":"Cosorich I, Dalla-Costa G, Sorini C et al (2017) High frequency of intestinal TH 17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.1700492","journal-title":"Sci Adv"},{"key":"2429_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ana.26084","volume":"89","author":"LM Cox","year":"2021","unstructured":"Cox LM, Maghzi AH, Liu S et al (2021) Gut microbiome in progressive multiple sclerosis. Ann Neurol 89:1195\u20131211. https:\/\/doi.org\/10.1002\/ana.26084","journal-title":"Ann Neurol"},{"key":"2429_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1549102","author":"D Dai","year":"2025","unstructured":"Dai D, Cao G, Huang S et al (2025) Porphyromonas gingivalis exacerbates experimental autoimmune encephalomyelitis by driving Th1 differentiation via ZAP70\/NF-\u03baB signaling. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1549102","journal-title":"Front Immunol"},{"key":"2429_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2180316","author":"L Devolder","year":"2023","unstructured":"Devolder L, Pauwels A, Van Remoortel A et al (2023) Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis. Gut Microbes. https:\/\/doi.org\/10.1080\/19490976.2023.2180316","journal-title":"Gut Microbes"},{"key":"2429_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/635052","volume":"2015","author":"TFC Fraga-Silva","year":"2015","unstructured":"Fraga-Silva TFC, Mimura LAN, Marchetti CM et al (2015) Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection. J Immunol Res 2015:1\u201311. https:\/\/doi.org\/10.1155\/2015\/635052","journal-title":"J Immunol Res"},{"key":"2429_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.890298","author":"F Gargano","year":"2022","unstructured":"Gargano F, Guerrera G, Piras E et al (2022) Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brain. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.890298","journal-title":"Front Immunol"},{"key":"2429_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2413953122","author":"S Ghimire","year":"2025","unstructured":"Ghimire S, Lehman PC, Aguilar Meza LS et al (2025) Specific microbial ratio in the gut microbiome is associated with multiple sclerosis. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.2413953122","journal-title":"Proc Natl Acad Sci USA"},{"key":"2429_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","volume":"21","author":"A Goris","year":"2022","unstructured":"Goris A, Vandebergh M, McCauley JL et al (2022) Genetics of multiple sclerosis: lessons from polygenicity. Lancet Neurol 21:830\u2013842. https:\/\/doi.org\/10.1016\/S1474-4422(22)00255-1","journal-title":"Lancet Neurol"},{"key":"2429_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211007687","author":"S Haase","year":"2021","unstructured":"Haase S, Linker RA (2021) Inflammation in multiple sclerosis. Ther Adv Neurol Disord. https:\/\/doi.org\/10.1177\/17562864211007687","journal-title":"Ther Adv Neurol Disord"},{"key":"2429_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, AL-Biati HA, Al-Tameemi ZS et al (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine 103:e37297. https:\/\/doi.org\/10.1097\/MD.0000000000037297","journal-title":"Medicine"},{"key":"2429_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1212\/WNL.0b013e3181e24124","volume":"74","author":"L Handunnetthi","year":"2010","unstructured":"Handunnetthi L, Ramagopalan SV, Ebers GC (2010) Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 74:1905\u20131910. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e24124","journal-title":"Neurology"},{"key":"2429_CR25","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1177\/13524585211001781","volume":"27","author":"A Harroud","year":"2021","unstructured":"Harroud A, Mitchell RE, Richardson TG et al (2021) Childhood obesity and multiple sclerosis: a Mendelian randomization study. Mult Scler J 27:2150\u20132158. https:\/\/doi.org\/10.1177\/13524585211001781","journal-title":"Mult Scler J"},{"key":"2429_CR26","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1352458515603798","volume":"22","author":"A Hedstr\u00f6m","year":"2016","unstructured":"Hedstr\u00f6m A, Olsson T, Alfredsson L (2016) Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult Scler J 22:878\u2013883. https:\/\/doi.org\/10.1177\/1352458515603798","journal-title":"Mult Scler J"},{"key":"2429_CR27","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/acn3.51441","volume":"8","author":"MK Horton","year":"2021","unstructured":"Horton MK, McCauley K, Fadrosh D et al (2021) Gut microbiome is associated with multiple sclerosis activity in children. Ann Clin Transl Neurol 8:1867\u20131883. https:\/\/doi.org\/10.1002\/acn3.51441","journal-title":"Ann Clin Transl Neurol"},{"key":"2429_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.24938","volume":"81","author":"P Iaffaldano","year":"2017","unstructured":"Iaffaldano P, Simone M, Lucisano G et al (2017) Prognostic indicators in pediatric clinically isolated syndrome. Ann Neurol 81:729\u2013739. https:\/\/doi.org\/10.1002\/ana.24938","journal-title":"Ann Neurol"},{"key":"2429_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"D Jakimovski","year":"2024","unstructured":"Jakimovski D, Bittner S, Zivadinov R et al (2024) Multiple sclerosis. Lancet 403:183\u2013202. https:\/\/doi.org\/10.1016\/S0140-6736(23)01473-3","journal-title":"Lancet"},{"key":"2429_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM et al (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015. https:\/\/doi.org\/10.1038\/ncomms12015","journal-title":"Nat Commun"},{"key":"2429_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028928","volume":"8","author":"S Klineova","year":"2018","unstructured":"Klineova S, Lublin FD (2018) Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med 8:a028928. https:\/\/doi.org\/10.1101\/cshperspect.a028928","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2429_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12866-019-1685-2","volume":"19","author":"M Kozhieva","year":"2019","unstructured":"Kozhieva M, Naumova N, Alikina T et al (2019) Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity. BMC Microbiol 19:309. https:\/\/doi.org\/10.1186\/s12866-019-1685-2","journal-title":"BMC Microbiol"},{"key":"2429_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T et al (2023) Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol 22:78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7","journal-title":"Lancet Neurol"},{"key":"2429_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/B978-0-444-52001-2.00002-9","volume":"122","author":"A Kutzelnigg","year":"2014","unstructured":"Kutzelnigg A, Lassmann H (2014) Pathology of multiple sclerosis and related inflammatory demyelinating diseases. Handb Clin Neurol 122:15\u201358. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00002-9","journal-title":"Handb Clin Neurol"},{"key":"2429_CR35","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/00220345221102084","volume":"101","author":"X Li","year":"2022","unstructured":"Li X, Kiprowska M, Kansara T et al (2022) Neuroinflammation: a distal consequence of periodontitis. J Dent Res 101:1441\u20131449. https:\/\/doi.org\/10.1177\/00220345221102084","journal-title":"J Dent Res"},{"key":"2429_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-024-01364-x","volume":"16","author":"Q Lin","year":"2024","unstructured":"Lin Q, Dorsett Y, Mirza A et al (2024) Meta-analysis identifies common gut microbiota associated with multiple sclerosis. Genome Med 16:94. https:\/\/doi.org\/10.1186\/s13073-024-01364-x","journal-title":"Genome Med"},{"key":"2429_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300415","volume":"19","author":"NB Lomer","year":"2024","unstructured":"Lomer NB, Asalemi KA, Saberi A, Sarlak K (2024) Predictors of multiple sclerosis progression: a systematic review of conventional magnetic resonance imaging studies. PLoS ONE 19:e0300415. https:\/\/doi.org\/10.1371\/journal.pone.0300415","journal-title":"PLoS ONE"},{"key":"2429_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis. Neurology 46:907\u2013911. https:\/\/doi.org\/10.1212\/WNL.46.4.907","journal-title":"Neurology"},{"key":"2429_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis. Neurology 83:278\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"2429_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/genes12081181","volume":"12","author":"A Maglione","year":"2021","unstructured":"Maglione A, Zuccal\u00e0 M, Tosi M et al (2021) Host genetics and gut microbiome: perspectives for multiple sclerosis. Genes 12:1181. https:\/\/doi.org\/10.3390\/genes12081181","journal-title":"Genes"},{"key":"2429_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O et al (2015) A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler J 21:263\u2013281. https:\/\/doi.org\/10.1177\/1352458514564491","journal-title":"Mult Scler J"},{"key":"2429_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jneuroim.2018.07.015","volume":"329","author":"S Miyake","year":"2019","unstructured":"Miyake S, Yamamura T (2019) Gut environmental factors and multiple sclerosis. J Neuroimmunol 329:20\u201323. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.07.015","journal-title":"J Neuroimmunol"},{"key":"2429_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake S, Kim S, Suda W et al (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS ONE 10:e0137429. https:\/\/doi.org\/10.1371\/journal.pone.0137429","journal-title":"PLoS ONE"},{"key":"2429_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05936-y","volume":"12","author":"E Miyauchi","year":"2022","unstructured":"Miyauchi E, Taida T, Kawasumi M et al (2022) Analysis of colonic mucosa-associated microbiota using endoscopically collected lavage. Sci Rep 12:1758. https:\/\/doi.org\/10.1038\/s41598-022-05936-y","journal-title":"Sci Rep"},{"key":"2429_CR45","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-025-04728-5","volume":"62","author":"E Mohsen","year":"2025","unstructured":"Mohsen E, Haffez H, Ahmed S et al (2025) Multiple sclerosis: a story of the interaction between gut microbiome and components of the immune system. Mol Neurobiol 62:7762\u20137775. https:\/\/doi.org\/10.1007\/s12035-025-04728-5","journal-title":"Mol Neurobiol"},{"key":"2429_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960761","author":"L Moles","year":"2022","unstructured":"Moles L, Delgado S, Gorostidi-Aicua M et al (2022) Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.960761","journal-title":"Front Immunol"},{"key":"2429_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/imj.70023","volume":"55","author":"T Montague","year":"2025","unstructured":"Montague T, Drummond J, Ng K, Parratt J (2025) Advancements in multiple sclerosis. Intern Med J 55:895\u2013904. https:\/\/doi.org\/10.1111\/imj.70023","journal-title":"Intern Med J"},{"key":"2429_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/imr.13343","volume":"325","author":"TL Montgomery","year":"2024","unstructured":"Montgomery TL, Peipert D, Krementsov DN (2024) Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: complex interactions between host genetics, bacterial metabolism, and diet. Immunol Rev 325:131\u2013151. https:\/\/doi.org\/10.1111\/imr.13343","journal-title":"Immunol Rev"},{"key":"2429_CR49","unstructured":"Multiple Sclerosis International Federation (2020) Atlas of MS: Number of people with MS worldwide. https:\/\/atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms. Accessed 10 Mar 2026"},{"key":"2429_CR50","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1177\/1352458513507357","volume":"19","author":"KL Munger","year":"2013","unstructured":"Munger KL (2013) Childhood obesity is a risk factor for multiple sclerosis. Mult Scler J 19:1800\u20131800. https:\/\/doi.org\/10.1177\/1352458513507357","journal-title":"Mult Scler J"},{"key":"2429_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14111120","volume":"14","author":"R Nistri","year":"2024","unstructured":"Nistri R, Ianniello A, Pozzilli V et al (2024) Advanced MRI techniques: diagnosis and follow-up of multiple sclerosis. Diagnostics 14:1120. https:\/\/doi.org\/10.3390\/diagnostics14111120","journal-title":"Diagnostics"},{"key":"2429_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241915024","volume":"24","author":"Z Nitzan","year":"2023","unstructured":"Nitzan Z, Staun-Ram E, Volkowich A, Miller A (2023) Multiple sclerosis-associated gut microbiome in the Israeli diverse populations: associations with ethnicity, gender, disability status, vitamin D levels, and Mediterranean diet. Int J Mol Sci 24:15024. https:\/\/doi.org\/10.3390\/ijms241915024","journal-title":"Int J Mol Sci"},{"key":"2429_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13111524","volume":"13","author":"V Nociti","year":"2023","unstructured":"Nociti V, Romozzi M (2023) The importance of managing modifiable comorbidities in people with multiple sclerosis: a narrative review. J Pers Med 13:1524. https:\/\/doi.org\/10.3390\/jpm13111524","journal-title":"J Pers Med"},{"key":"2429_CR54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/brain\/awab320","volume":"145","author":"A Ntranos","year":"2022","unstructured":"Ntranos A, Park H-J, Wentling M et al (2022) Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma. Brain 145:569\u2013583. https:\/\/doi.org\/10.1093\/brain\/awab320","journal-title":"Brain"},{"key":"2429_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13:25\u201336. https:\/\/doi.org\/10.1038\/nrneurol.2016.187","journal-title":"Nat Rev Neurol"},{"key":"2429_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718220","author":"B Parodi","year":"2021","unstructured":"Parodi B, Kerlero de Rosbo N (2021) The gut-brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease? Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.718220","journal-title":"Front Immunol"},{"key":"2429_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1655428","author":"D Peipert","year":"2025","unstructured":"Peipert D, Montgomery TL, Toppen LC et al (2025) Colonization by Akkermansia muciniphila modulates central nervous system autoimmunity in an ecological context-dependent manner. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1655428","journal-title":"Front Immunol"},{"key":"2429_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mayocpiqo.2021.11.004","volume":"6","author":"MD Peterson","year":"2022","unstructured":"Peterson MD, Lin P, Kamdar N et al (2022) Physical and mental health comorbidities among adults with multiple sclerosis. Mayo Clin Proc Innov Qual Outcomes 6:55\u201368. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.11.004","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2429_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2024.1342166","author":"S Poli","year":"2024","unstructured":"Poli S, Donisi V, Mazzi MA et al (2024) Fostering quality of life in young adults living with multiple sclerosis: a pilot study of a co-created integrated intervention. Front Psychol. https:\/\/doi.org\/10.3389\/fpsyg.2024.1342166","journal-title":"Front Psychol"},{"key":"2429_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100977","volume":"44","author":"E Portaccio","year":"2024","unstructured":"Portaccio E, Magyari M, Havrdova EK et al (2024) Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur 44:100977. https:\/\/doi.org\/10.1016\/j.lanepe.2024.100977","journal-title":"Lancet Reg Health Eur"},{"key":"2429_CR61","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jnnp-2022-329049","volume":"93","author":"L Prosperini","year":"2022","unstructured":"Prosperini L, Lucchini M, Ruggieri S et al (2022) Shift of multiple sclerosis onset towards older age. J Neurol Neurosurg Psychiatry 93:1137\u20131139. https:\/\/doi.org\/10.1136\/jnnp-2022-329049","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2429_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaz6563","author":"T Regen","year":"2021","unstructured":"Regen T, Isaac S, Amorim A et al (2021) IL-17 controls central nervous system autoimmunity through the intestinal microbiome. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aaz6563","journal-title":"Sci Immunol"},{"key":"2429_CR63","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/acn3.51004","volume":"7","author":"T Reynders","year":"2020","unstructured":"Reynders T, Devolder L, Valles\u2010Colomer M et al (2020) Gut microbiome variation is associated to multiple sclerosis phenotypic subtypes. Ann Clin Transl Neurol 7:406\u2013419. https:\/\/doi.org\/10.1002\/acn3.51004","journal-title":"Ann Clin Transl Neurol"},{"key":"2429_CR64","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209135","author":"A Salter","year":"2024","unstructured":"Salter A, Lancia S, Kowalec K et al (2024) Investigating the prevalence of comorbidity in multiple sclerosis clinical trial populations. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000209135","journal-title":"Neurology"},{"key":"2429_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103557","volume":"71","author":"S Shah","year":"2021","unstructured":"Shah S, Locca A, Dorsett Y et al (2021) Alterations of the gut mycobiome in patients with MS. EBioMedicine 71:103557. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103557","journal-title":"EBioMedicine"},{"key":"2429_CR66","doi-asserted-by":"publisher","first-page":"627","DOI":"10.4049\/immunohorizons.2100024","volume":"5","author":"SK Shahi","year":"2021","unstructured":"Shahi SK, Ali S, Jaime CM et al (2021) HLA class II polymorphisms modulate gut microbiota and experimental autoimmune encephalomyelitis phenotype. Immunohorizons 5:627\u2013646. https:\/\/doi.org\/10.4049\/immunohorizons.2100024","journal-title":"Immunohorizons"},{"key":"2429_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2018","unstructured":"Sintzel MB, Rametta M, Reder AT (2018) Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther 7:59\u201385. https:\/\/doi.org\/10.1007\/s40120-017-0086-4","journal-title":"Neurol Ther"},{"key":"2429_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21:51\u201364. https:\/\/doi.org\/10.1038\/s41579-022-00770-5","journal-title":"Nat Rev Microbiol"},{"key":"2429_CR69","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/s41564-024-01761-3","volume":"9","author":"A Steimle","year":"2024","unstructured":"Steimle A, Neumann M, Grant ET et al (2024) Gut microbial factors predict disease severity in a mouse model of multiple sclerosis. Nat Microbiol 9:2244\u20132261. https:\/\/doi.org\/10.1038\/s41564-024-01761-3","journal-title":"Nat Microbiol"},{"key":"2429_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604987","author":"X Sun","year":"2025","unstructured":"Sun X, Zhang F, Wang L et al (2025) Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1604987","journal-title":"Front Immunol"},{"key":"2429_CR71","doi-asserted-by":"publisher","first-page":"22402","DOI":"10.1073\/pnas.2011703117","volume":"117","author":"D Takewaki","year":"2020","unstructured":"Takewaki D, Suda W, Sato W et al (2020) Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc Natl Acad Sci USA 117:22402\u201322412. https:\/\/doi.org\/10.1073\/pnas.2011703117","journal-title":"Proc Natl Acad Sci USA"},{"key":"2429_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1451","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Rickinson A, Palendira U (2023) Epstein-Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism. Clin Transl Immunol. https:\/\/doi.org\/10.1002\/cti2.1451","journal-title":"Clin Transl Immunol"},{"key":"2429_CR73","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jama.2025.1604","volume":"333","author":"E Thouvenot","year":"2025","unstructured":"Thouvenot E, Laplaud D, Lebrun-Frenay C et al (2025) High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis. JAMA 333:1413. https:\/\/doi.org\/10.1001\/jama.2025.1604","journal-title":"JAMA"},{"key":"2429_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07336-8","volume":"12","author":"A Troci","year":"2022","unstructured":"Troci A, Zimmermann O, Esser D et al (2022) B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients. Sci Rep 12:3728. https:\/\/doi.org\/10.1038\/s41598-022-07336-8","journal-title":"Sci Rep"},{"key":"2429_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71939-2","volume":"10","author":"S Vaga","year":"2020","unstructured":"Vaga S, Lee S, Ji B et al (2020) Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals. Sci Rep 10:14977. https:\/\/doi.org\/10.1038\/s41598-020-71939-2","journal-title":"Sci Rep"},{"key":"2429_CR76","doi-asserted-by":"crossref","unstructured":"Wragge-Morley A (2018) Imagining the soul: Thomas Willis (1621\u20131675) on the anatomy of the brain and nerves. pp 55\u201373","DOI":"10.1016\/bs.pbr.2018.10.009"},{"key":"2429_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106535","volume":"100","author":"V Zancan","year":"2025","unstructured":"Zancan V, Nasello M, Diamant S et al (2025) Influence of oral and skin microbiota on multiple sclerosis risk and severity: a mendelian randomization analysis. Mult Scler Relat Disord 100:106535. https:\/\/doi.org\/10.1016\/j.msard.2025.106535","journal-title":"Mult Scler Relat Disord"},{"key":"2429_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260384","volume":"16","author":"Z Zangeneh","year":"2021","unstructured":"Zangeneh Z, Abdi-Ali A, Khamooshian K et al (2021) Bacterial variation in the oral microbiota in multiple sclerosis patients. PLoS ONE 16:e0260384. https:\/\/doi.org\/10.1371\/journal.pone.0260384","journal-title":"PLoS ONE"},{"key":"2429_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104468","volume":"129","author":"Q Zeng","year":"2019","unstructured":"Zeng Q, Gong J, Liu X et al (2019) Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Neurochem Int 129:104468. https:\/\/doi.org\/10.1016\/j.neuint.2019.104468","journal-title":"Neurochem Int"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-026-02429-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:04:16Z","timestamp":1791857056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-026-02429-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2429"],"URL":"https:\/\/doi.org\/10.1007\/s10482-026-02429-0","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"219"}}